GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
- Status
- COMPLETED
- Phase
- N/A
Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT
- Status
- COMPLETED
- Phase
- N/A
Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- N/A
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy for Advanced Liver Cancer
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SBRT With DIBH for HCC After TACE and Lipiodol Marking
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
- Status
- RECRUITING
- Phase
- N/A
Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy
- Status
- UNKNOWN
- Phase
- PHASE2